Participant flow

Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) · Source last updated 2018-01-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Pazopanib 400 mg QD - Gemcitabine and Docetaxel in Combination with Pazopanib

   id

   FG000

   title

   Pazopanib 400 mg QD

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         5

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         5

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice